- What We Do
- Agriculture and Food Security
- Democracy, Human Rights and Governance
- Economic Growth and Trade
- Education
- Ending Extreme Poverty
- Environment and Global Climate Change
- Gender Equality and Women's Empowerment
- Global Health
- Water and Sanitation
- Working in Crises and Conflict
- U.S. Global Development Lab
-
National Action Plan for Combating Multidrug-Resistant Tuberculosis
-
Through technical assistance led by the U.S. Agency for International Development (USAID) and our innovative partnership with Johnson & Johnson, we are scaling up multidrug-resistant TB treatment programs in over 25 countries.
-
As the lead U.S. Government agency for global TB care, USAID works with partners to reach every person with TB, cure those in need of treatment and prevent new TB infections.
-
TB and poverty are inextricably linked. Poor individuals are threefold more likely to develop TB, and TB plunges households further into poverty.
Tuberculosis (TB) is the leading infectious disease killer globally, yet it is both preventable and curable. In 2015:
![Graphic of a man coughing - 10.4 million new cases of TB](https://webarchive.library.unt.edu/web/20170207004910im_/https://www.usaid.gov/sites/default/files/nodeimage/10p4million-newTBcases_3.jpg)
![Graphic of two pills. 4.3 million TB cases missing out on proper care](https://webarchive.library.unt.edu/web/20170207004910im_/https://www.usaid.gov/sites/default/files/nodeimage/4p3million-TBcare.jpg)
![Graphic of a pair of lungs. 1.8 million deaths from TB](https://webarchive.library.unt.edu/web/20170207004910im_/https://www.usaid.gov/sites/default/files/nodeimage/1p8million-TBdeaths.jpg)
![Graphic of a microscope. 580,000 new drug-resistant TB cases](https://webarchive.library.unt.edu/web/20170207004910im_/https://www.usaid.gov/sites/default/files/nodeimage/580k-TBdrug.jpg)
News & Updates
- U.S. Government Report to Congress for Tuberculosis FY15 [PDF, 3.9MB]
- World Health Organization Global TB Report 2016 [PDF, 6.4MB]
The U.S. Agency for International Development (USAID) supports high-quality screening, diagnosis and treatment services for millions of people affected by TB and multidrug-resistant tuberculosis (MDR-TB). In Fiscal Year 2015, with investments of $242 million focused primarily in 23 countries with bilateral TB funds, the U.S. Government achieved the following results in collaboration with each country's programs:
- More than 3.7 million TB cases detected and diagnosed.
- More than 2.8 million people provided with TB treatment.
- More than 70,000 people with MDR-TB started on appropriate treatment.
USAID's FY 2015 investments contributed to an estimated 49 million lives saved from 2000-2015, including people co-infected with HIV and AIDS, leading to a 22 percent decline in TB mortality and a 21 percent decline in TB incidence globally since 2000.
- Know your epidemic – tailor programs to local settings
- Target high-risk groups
- Engage all care providers and facilities
- Strengthen the capacity of local partners
- Maximize domestic and private sector resources
- Support Global Fund grant implementation
- Support strong monitoring and evaluation
- Match evidence-based science with innovative approaches
What We Do
At USAID, we focus our investments on strengthening national TB strategies and programs in 23 priority countries with high rates of TB, drug-resistant TB and HIV-associated TB.
USAID works with partner governments to:
- Prevent TB transmission and renew efforts to find the missing TB cases
- Strengthen the capacity of national TB programs
- Build country capacity to use existing resources and to turn evidence into policy
- Expand the development of new TB diagnostics, drugs and vaccines
Last updated: February 02, 2017
Comment
Make a general inquiry or suggest an improvement.